0
contact-banner

Deucravacitinib

Deucravacitinib

API0233015

Deucravacitinib

Deucravacitinib is used for the treatment of psoriasis.

Inquiry
API Description
API Details
Document
Related Patent Status
  • CAS No.

    1609392-27-9

  • Synonyms

    Deucravacitinib; 1609392-27-9; BMS-986165

  • CHEMBL ID

    CHEMBL4435170

  • Molecule Type

    Small molecule

  • Compound CID

    134821691

  • Molecular Weight (g/mol)

    425.5

  • Molecular Formula

    C20H22N8O3

  • InChI

    InChI=1S/C20H22N8O3/c1-21-20(30)16-14(9-15(25-26-16)24-19(29)11-7-8-11)23-13-6-4-5-12(17(13)31-3)18-22-10-28(2)27-18/h4-6,9-11H,7-8H2,1-3H3,(H,21,30)(H2,23,24,25,29)/i1D3

  • InChIKey

    BZZKEPGENYLQSC-FIBGUPNXSA-N

  • SMILES

    [2H]C([2H])([2H])NC(=O)C1=NN=C(C=C1NC2=CC=CC(=C2OC)C3=NN(C=N3)C)NC(=O)C4CC4

  • IUPAC Name

    6-(cyclopropanecarbonylamino)-4-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-N-(trideuteriomethyl)pyridazine-3-carboxamide

  • Exact Mass (Da)

    425.20031683

  • Monoisotopic Mass (Da)

    425.20031683

OUR PRODUCTS

  • API0232809

    Abemaciclib

    Abemaciclib

    1231929-97-7

    Learn More
  • API0231523

    Alpha-Tocopherol Acetate

    Alpha-Tocopherol Acetate

    52225-20-4

    Learn More
  • API0232867

    Lotilaner

    Lotilaner

    1369852-71-0

    Learn More
  • API0232096

    Iothalamate Meglumine

    Iothalamate Meglumine

    2276-90-6

    Learn More